1. Home
  2. ORIC

ORIC

Oric Pharmaceuticals Inc.

Logo Oric Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 11:29am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.

Founded: 2014 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 660.3M IPO Year: 2020
Target Price: $21.33 AVG Volume (30 days): 612.0K
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.96 EPS Growth: N/A
52 Week Low/High: $4.89 - $16.65 Next Earning Date: 05-06-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: